Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine to Reduce Coronary Artery Inflammation in People With HIV
NCT07704164Phase 2Recruiting
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in cardiovascular disease (CVD), sponsored by Hospital La Paz Institute for Health Research. Started Jun 2026; status: recruiting.
02
Drugs
colchicine
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT07704164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704164.